Novel Therapeutics for the Treatment of Familial Mediterranean Fever: From Colchicine to Biologics

Rilonacept for Colchicine-Resistant or -Intolerant Familial Mediterranean Fever

(2013) Philip J. Hashkes et al.   ANNALS OF INTERNAL MEDICINE

IL-1β Biological Treatment of Familial Mediterranean Fever

(2013) Alessandra Soriano et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

Efficacy and Safety of Biologic Treatments in Familial Mediterranean Fever

(2012) Akgu Ozgur et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

A novel mutation in the albumin gene (c.1A>C) resulting in analbuminemia

(2012) Gianluca Caridi et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Effects of Anti-Tumor Necrosis Factor Agents for Familial Mediterranean Fever Patients With Chronic Arthritis and/or Sacroiliitis Who Were Resistant to Colchicine Treatment

(2012) Sule Apras Bilgen et al.   JCR-JOURNAL OF CLINICAL RHEUMATOLOGY

Canakinumab induces remission in a patient with resistant familial Mediterranean fever

(2012) D. O. Hacihamdioglu et al.   RHEUMATOLOGY

The efficacy of canakinumab in the treatment of a patient with familial Mediterranean fever and longstanding destructive arthritis

(2011) I. Mitroulis et al.   ANNALS OF THE RHEUMATIC DISEASES

Comprehensive Analysis of a Large-Scale Screen for MEFV Gene Mutations: Do They Truly Provide a “Heterozygote Advantage” in Turkey?

(2011) Afig Berdeli et al.   Genetic Testing and Molecular Biomarkers

Gain-of-Function Pyrin Mutations Induce NLRP3 Protein-Independent Interleukin-1β Activation and Severe Autoinflammation in Mice

(2011) Jae Jin Chae et al.   IMMUNITY

Dramatic beneficial effect of interleukin-1 inhibitor treatment in patients with familial Mediterranean fever complicated with amyloidosis and renal failure

(2011) K. Stankovic Stojanovic et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Interleukin-1 Targeting Drugs in Familial Mediterranean Fever: A Case Series and a Review of the Literature

(2011) Ulrich Meinzer et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Colchicine in clinical medicine. A guide for internists

(2010) Giuseppe Cocco et al.   European Journal of Internal Medicine

Targeting IL-1β in disease; the expanding role of NLRP3 inflammasome

(2010) Ioannis Mitroulis et al.   European Journal of Internal Medicine

Anti-Interleukin 1 Treatment for Patients with Familial Mediterranean Fever Resistant to Colchicine: Table 1.

(2010) SEZA ÖZEN et al.   JOURNAL OF RHEUMATOLOGY

Pneumonia in a patient with familial Mediterranean fever successfully treated with anakinra—case report and review

(2010) Stefanie Hennig et al.   RHEUMATOLOGY INTERNATIONAL

Efficacy of anakinra treatment in a patient with colchicine-resistant familial Mediterranean fever

(2010) Nilüfer Alpay et al.   RHEUMATOLOGY INTERNATIONAL

Transmission of Familial Mediterranean Fever Mutation After Bone Marrow Transplantation and Successful Treatment With Anakinra

(2010) Anna D. Petropoulou et al.   TRANSPLANTATION

Clinical features and functional significance of the P369S/R408Q variant in pyrin, the familial Mediterranean fever protein

(2009) J. G. Ryan et al.   ANNALS OF THE RHEUMATIC DISEASES

Horror Autoinflammaticus: The Molecular Pathophysiology of Autoinflammatory Disease

(2009) Seth L. Masters et al.   Annual Review of Immunology

Familial Mediterranean Fever in the World

(2009) Eldad Ben-Chetrit et al.   ARTHRITIS AND RHEUMATISM

Anti-IL-1 treatment for secondary amyloidosis in an adolescent with FMF and Behçet’s disease

(2009) Yelda Bilginer et al.   CLINICAL RHEUMATOLOGY

The infevers autoinflammatory mutation online registry: update with new genes and functions

(2008) Florian Milhavet et al.   HUMAN MUTATION

Anakinra: New therapeutic approach in children with Familial Mediterranean Fever resistant to colchicine

(2008) Rosa Roldan et al.   JOINT BONE SPINE

Successful treatment of familial Mediterranean fever with Anakinra and outcome after renal transplantation

(2008) C. Moser et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Colchicine Update: 2008

(2008) Robert A. Terkeltaub   SEMINARS IN ARTHRITIS AND RHEUMATISM

The human anti-IL-1β monoclonal antibody ACZ885 is effective in joint inflammation models in mice and in a proof-of-concept study in patients with rheumatoid arthritis

(2008) Rieke Alten et al.   ARTHRITIS RESEARCH & THERAPY